Acute normovolemic hemodilution in cardiac surgery: Rationale and design of a multicenter randomized trial – PubMed
This trial was registered on ClinicalTrials.gov in April 2019 with the trial identification number NCT03913481.
Related Articles
Paper of the Day
Join us to read 1 paper per day and stay up-to-date as we cover the spectrum of critical care across 2023
U.S. to Probe Reports of Antisemitic Incidents at Top Medical Schools
Lawyers from the Department of Health and Human Services have launched investigations of several medical schools, including Harvard’s.
Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease – PubMed
A range of therapies now exists to reduce the risk of kidney failure and cardiovascular events in people with type 2 diabetes, including renin-angiotensin system…
Solving Challenging Situations and Complications in Everyday Percutaneous Coronary Intervention Using Chronic Total Occlusion Techniques – PubMed
The field of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has witnessed a dramatic evolution in the last decade. The challenging nature of CTO…
One Health preparedness and response for mosquito-borne viruses: a stakeholder- and social network-analysis in the Netherlands – PubMed
The underrepresentation of the environment domain, regional and local stakeholders in the MBV preparedness and response network underlines the remaining challenge of including all relevant…
Five decades of research on psychological treatments of depression: A historical and meta-analytic overview – PubMed
Since the 1970s, hundreds of randomized trials have examined the effects of psychotherapies for depression, and this number is increasing every year. In this study,…
Should thrombolytics be given >4.5 hours after stroke onset?
Improved outcomes despite intracranial hemorrhages in a new meta-analysis
Critical Care Jobs | SCCM Career Center
Job Listings 1 – 25 (Out of 11309) Critical Care on SCCM Career Center.
Māori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR) – PubMed
MPP with MM in NZ were younger, a greater proportion had comorbidities and FISH abnormalities at diagnosis, fewer received first-line treatment and/or ASCT, and they…
